Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Mahesh Patil explains why the pharmaceutical industry must realign ORS formulat...
Sobi will purchase for Arthrosi Skr9.1bn ($950m) in cash. Additional payments of...
Rett syndrome is a rare neurodevelopmental disorder that progresses through four...
Lancet publication and ovarian cancer trial discussed at Kolkata meeting The po...
DCGI-approved extended-release formulation introduced for once-daily dosing in ...
State government to launch pharma and medical devices policy and announce indu...
The products are marketed as Diavorin and Vobexoryn through Pharmamedic B.V. T...
The multi-programme partnership leverages Zealand Pharma’s experience in obesity...
The approval marks the first new treatment for the adult population with PPF in ...
This next-generation central nervous system (CNS)-penetrant will be developed by...
The approvals mark the fourth and fifth clearances for the company in the countr...
The product will be marketed by Dr Reddy’s Laboratories The post Senores Phar...
The initiative was carried out under the company’s Laborate for Nature program...
The company outlines near-term and long-term emission reduction goals across i...
The partnership focuses on strengthening peptide API supply chains and supporti...
USFDA inspection confirms compliance at Indoco Remedies’ Active Pharmaceutical ...
